Post-initiation chemopreventive effects of dietary bovine lactoferrin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in female A/J mice

Cancer Letters

Volumn 246, Issue 1-2, 2007, Pages 41-46

  Matsuda, Yoko ^a   Saoo, Kousuke ^a   Hosokawa, Kyoko ^a   Yamakawa, Keiko ^a   Yokohira, Masanao ^a   Zeng, Yu ^a   Takeuchi, Hijiri ^a   Imaida, Katsumi ^a  

^a Kagawa Medical University   (Japan)

Author keywords

A J mouse; Bovine lactoferrin; NNK induced lung tumor

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BOVINE LACTOFERRIN; LACTOFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIETARY INTAKE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NODULE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOMA; ANIMALS; BODY WEIGHT; CASPASE 3; CATTLE; DIETARY SUPPLEMENTS; FEMALE; HYPERPLASIA; LACTOFERRIN; LUNG; LUNG NEOPLASMS; MICE; MICE, INBRED A; NITROSAMINES; ORGAN SIZE; PROLIFERATING CELL NUCLEAR ANTIGEN;

BOS TAURUS;

EID: 33845614930     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.01.034     Document Type: Article

References (26)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
2. Soria J.C., Kim E.S., Fayette J., Lantuejoul S., Deutsch E., and Hong W.K. Chemoprevention of lung cancer. Lancet Oncol. 4 (2003) 659-669
3. Lee B.M., and Park K.K. Beneficial and adverse effects of chemopreventive agents. Mutat. Res. 523-524 (2003) 265-278
4. Okada S., Tanaka K., Sato T., Ueno H., Saito S., Okusaka T., et al. Dose-response trial of lactoferrin in patients with chronic hepatitis C. Jpn. J. Cancer Res. 93 (2002) 1063-1069
5. Ishii K., Takamura N., Shinohara M., Wakui N., Shin H., Sumino Y., et al. Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months. Hepatol. Res. 25 (2003) 226-233
6. Choe Y.H., Oh Y.J., Lee N.G., Imoto I., Adachi Y., Toyoda N., et al. Lactoferrin sequestration and its contribution to iron-deficiency anemia in Helicobacter pylori-infected gastric mucosa. J. Gastroenterol. Hepatol. 18 (2003) 980-985
7. Dial E.J., and Lichtenberger L.M. Effect of lactoferrin on Helicobacter felis induced gastritis. Biochem. Cell Biol. 80 (2002) 113-117
8. Yang N., Stensen W., Svendsen J.S., and Rekdal O. Enhanced antitumor activity and selectivity of lactoferrin-derived peptides. J. Pept. Res. 60 (2002) 187-197
9. Vogel H.J., Schibli D.J., Jing W., Lohmeier-Vogel E.M., Epand R.F., and Epand R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol. 80 (2002) 49-63
10. Shimamura M., Yamamoto Y., Ashino H., Oikawa T., Hazato T., Tsuda H., et al. Bovine lactoferrin inhibits tumor-induced angiogenesis. Int. J. Cancer 111 (2004) 111-116
11. Tanaka T., Kawabata K., Kohno H., Honjo S., Murakami M., Ota T., et al. Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats. Jpn. J. Cancer Res. 91 (2000) 25-33
12. Masuda C., Wanibuchi H., Sekine K., Yano Y., Otani S., Kishimoto T., et al. Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis. Jpn. J. Cancer Res. 91 (2000) 582-588
13. Fujita K., Ohnishi T., Sekine K., Iigo M., and Tsuda H. Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats. Jpn. J. Cancer Res. 93 (2002) 616-625
14. Sekine K., Watanabe E., Nakamura J., Takasuka N., Kim D.J., Asamoto M., et al. Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn. J. Cancer Res. 88 (1997) 523-526
15. Sekine K., Ushida Y., Kuhara T., Iigo M., Baba-Toriyama H., Moore M.A., et al. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett. 121 (1997) 211-216
16. Ushida Y., Sekine K., Kuhara T., Takasuka N., Iigo M., and Tsuda H. Inhibitory effects of bovine lactoferrin on intestinal polyposis in the Apc(Min) mouse. Cancer Lett. 134 (1998) 141-145
17. Varadhachary A., Wolf J.S., Petrak K., O'Malley Jr. B.W., Spadaro M., Curcio C., et al. Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Int. J. Cancer 111 (2004) 398-403
18. Ushida Y., Sekine K., Kuhara T., Takasuka N., Iigo M., Maeda M., et al. Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis in the rat. Jpn. J. Cancer Res. 90 (1999) 262-267
19. Tsuda H., Sekine K., Takasuka N., Toriyama-Baba H., and Iigo M. Prevention of colon carcinogenesis and carcinoma metastasis by orally administered bovine lactoferrin in animals. Biofactors 12 (2000) 83-88
20. Takeuchi H., Saoo K., Yokohira M., Ikeda M., Maeta H., Miyazaki M., et al. Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Cancer Res. 63 (2003) 7581-7583
21. Estensen R.D., Jordan M.M., Wiedmann T.S., Galbraith A.R., Steele V.E., and Wattenberg L.W. Effect of chemopreventive agents on separate stages of progression of benzo[alpha]pyrene induced lung tumors in A/J mice. Carcinogenesis 25 (2004) 197-201
22. Dungworth D.L., Rittinghausen S., Schwartz L., Harkema J.R., Hayashi Y., Kittel B., et al. Respiratory system and mesothelium. In: Mohr U. (Ed). International Classification of Rodent Tumors: The Mouse (2001), Springer, Heiderberg 87-137
23. Fujita K., Matsuda E., Sekine K., Iigo M., and Tsuda H. Lactoferrin modifies apoptosis-related gene expression in the colon of the azoxymethane-treated rat. Cancer Lett. 213 (2004) 21-29
24. Kohno H., Taima M., Sumida T., Azuma Y., Ogawa H., and Tanaka T. Inhibitory effect of mandarin juice rich in beta-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice. Cancer Lett. 174 (2001) 141-150
25. Gown A.M., and Willingham M.C. Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. J. Histochem. Cytochem. 50 (2002) 449-454
26. Wakabayashi H., Kurokawa M., Shin K., Teraguchi S., Tamura Y., and Shiraki K. Oral lactoferrin prevents body weight loss and increases cytokine responses during herpes simplex virus type 1 infection of mice. Biosci. Biotechnol. Biochem. 68 (2004) 537-544